Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: CARDINAL HEALTH 127 INC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-27 to 2024-03-22
Current total value of award: $727361.96
Description: EO14042 VALIDATION OF A NOVEL METHODOLOGY FOR ENDPOINTS ASSESSING RESPONSE TO LYMPHOMA TREATMENT IN REAL-WORLD STUDIES